疑难病杂志
疑難病雜誌
의난병잡지
JOURNAL OF DIFFICULT AND COMPLICATED CASES
2015年
5期
472-475
,共4页
冯四平%王治国%安文军%张席军
馮四平%王治國%安文軍%張席軍
풍사평%왕치국%안문군%장석군
原发性膜性肾病%雷公藤多苷片%疗效%凝血纤溶系统%内皮细胞功能
原髮性膜性腎病%雷公籐多苷片%療效%凝血纖溶繫統%內皮細胞功能
원발성막성신병%뢰공등다감편%료효%응혈섬용계통%내피세포공능
Idiopathic membranous nephropathy%Tripterygium wilfordii%Curative effect%Coagulation fibrindytic sys-tem%Endothelial cell function
目的:观察雷公藤多苷片辅助治疗原发性膜性肾病( IMN)的疗效及对凝血纤溶系统、内皮细胞功能的影响。方法选取2012年6月—2014年7月接受治疗的IMN患者240例,按入院顺序随机分为2组,对照组120例采用小剂量激素等综合治疗方案,观察组120例在对照组基础上加用雷公藤多苷片治疗(20 mg口服,3次/d)。随访6个月,观察对比2组疗效及不良反应,测定2组24 h尿蛋白定量、血清白蛋白( Alb)、总胆固醇( TC)以及三酰甘油( TG)、丙氨酸氨基转移酶( ALT)、天冬氨酸氨基转移酶( AST)含量,并检查2组患者治疗前后血浆中组织纤溶酶原激活因子( t-PA )、I 型纤溶酶原激活因子抑制因子( PAI-I )以及内皮素-I ( ET-I )水平。结果观察组总有效率为87.50%,明显高于对照组的54.17%(χ2=32.27, P <0.05)。治疗后2组24 h尿蛋白、TC、TG明显低于治疗前,而Alb高于治疗前( P <0.05);且观察组改善情况均优于对照组( P <0.05)。观察组治疗后PAI-I和ET-I均明显降低, t-PA明显升高( P <0.05),对照组治疗前后t-PA、PAI-I、ET-I等3项指标差异均无统计学意义( P >0.05),2组治疗后比较差异亦具有统计学意义( P <0.05)。结论雷公藤多苷片辅助治疗IMN安全有效,能够改善凝血纤溶系统以及保护细胞内皮功能。
目的:觀察雷公籐多苷片輔助治療原髮性膜性腎病( IMN)的療效及對凝血纖溶繫統、內皮細胞功能的影響。方法選取2012年6月—2014年7月接受治療的IMN患者240例,按入院順序隨機分為2組,對照組120例採用小劑量激素等綜閤治療方案,觀察組120例在對照組基礎上加用雷公籐多苷片治療(20 mg口服,3次/d)。隨訪6箇月,觀察對比2組療效及不良反應,測定2組24 h尿蛋白定量、血清白蛋白( Alb)、總膽固醇( TC)以及三酰甘油( TG)、丙氨痠氨基轉移酶( ALT)、天鼕氨痠氨基轉移酶( AST)含量,併檢查2組患者治療前後血漿中組織纖溶酶原激活因子( t-PA )、I 型纖溶酶原激活因子抑製因子( PAI-I )以及內皮素-I ( ET-I )水平。結果觀察組總有效率為87.50%,明顯高于對照組的54.17%(χ2=32.27, P <0.05)。治療後2組24 h尿蛋白、TC、TG明顯低于治療前,而Alb高于治療前( P <0.05);且觀察組改善情況均優于對照組( P <0.05)。觀察組治療後PAI-I和ET-I均明顯降低, t-PA明顯升高( P <0.05),對照組治療前後t-PA、PAI-I、ET-I等3項指標差異均無統計學意義( P >0.05),2組治療後比較差異亦具有統計學意義( P <0.05)。結論雷公籐多苷片輔助治療IMN安全有效,能夠改善凝血纖溶繫統以及保護細胞內皮功能。
목적:관찰뢰공등다감편보조치료원발성막성신병( IMN)적료효급대응혈섬용계통、내피세포공능적영향。방법선취2012년6월—2014년7월접수치료적IMN환자240례,안입원순서수궤분위2조,대조조120례채용소제량격소등종합치료방안,관찰조120례재대조조기출상가용뢰공등다감편치료(20 mg구복,3차/d)。수방6개월,관찰대비2조료효급불량반응,측정2조24 h뇨단백정량、혈청백단백( Alb)、총담고순( TC)이급삼선감유( TG)、병안산안기전이매( ALT)、천동안산안기전이매( AST)함량,병검사2조환자치료전후혈장중조직섬용매원격활인자( t-PA )、I 형섬용매원격활인자억제인자( PAI-I )이급내피소-I ( ET-I )수평。결과관찰조총유효솔위87.50%,명현고우대조조적54.17%(χ2=32.27, P <0.05)。치료후2조24 h뇨단백、TC、TG명현저우치료전,이Alb고우치료전( P <0.05);차관찰조개선정황균우우대조조( P <0.05)。관찰조치료후PAI-I화ET-I균명현강저, t-PA명현승고( P <0.05),대조조치료전후t-PA、PAI-I、ET-I등3항지표차이균무통계학의의( P >0.05),2조치료후비교차이역구유통계학의의( P <0.05)。결론뢰공등다감편보조치료IMN안전유효,능구개선응혈섬용계통이급보호세포내피공능。
Objective To observe the effect of tripterygium glycosides tablet adjuvant treatment of idiopathic membra-nous nephropathy ( IMN) and the impact on blood coagulation fibrinolysis system and endothelial cells’ function.Methods From 2012 June to 2014 July, 240 IMN patients were randomly divided into 2 groups according to hospitalization order,120 cases in the control group received small dose of hormone and other comprehensive treatment, the observation group of 120 ca-ses based on the treatment of control group, also received tripterygium wilfordii glycoside tablet (2 mg by oral,3 times/d). Follow up of 6 months, and the adverse reactions of 2 groups were observed and the curative effect of 2 groups were compared, 24 h urine protein, serum albumin (Alb), total cholesterol (TC) and three acyl glycerides (TG), alanine aminotransferase ( ALT) , aspartate aminotransferase ( AST) levels were measured, and before and after treatment, plasma tissue plasminogen activator ( t-PA) , I type plasminogen activator inhibitor ( PAI-I ) and endothelin-1 ( ET-1 ) level were checked in the 2 groups.Results Total effective rate of observation group was 87.50%, which was significantly higher than that of control group’s 54.17%(χ2 =32.27, P <0.05).After treatment, 24 h urine protein TC, TG in the 2 groups were significantly lower than that before treatment, while Alb was higher than that before treatment;observation group were better than those in control group ( P <0.05).The observation group after treatment, PAI-I and ET-1 were decreased, t-PA was increased sig-nificantly ( P <0.05), before and after treatment in control group, t-PA, PAI-I, ET-1 did not show significant differences (P >0.05), after treatment, the 2 groups also showed statistically significant differences ( P <0.05).Conclusion Tripterygium wilfordii glycosides tablet adjuvant therapy for IMN is safe and effective, and can improve the coagulation fibri-nolysis system and protect endothelial cell function.